The Federal Trade Commission has paused an enforcement action alleging pharmacy benefit managers used illegal rebate programs ...

The FTC filed a lawsuit in September, accusing the three major PBMs of anticompetitive rebating practices related to insulin.

Please provide your email address to receive an email when new articles are posted on . The “big three” pharmacy benefit managers have imposed markups ranging from 100% to more than 7,000% on ...

A new FTC report claims that pharmacy benefit managers generated $7.3bn by marking up specialty generics used to treat diseases like cancer and HIV.

President Donald Trump’s move to fire two Democrats on the Federal Trade Commission leaves a question mark over the future of ...

The largest pharmacy-benefit managers hiked the prices of dozens of drugs dispensed through their own pharmacies, according to a new report by the Federal Trade Commission released on Tuesday.

A long-awaited report from the US Federal Trade Commission (FTC) on pharmacy benefit managers (PBMs) is out – and will make uncomfortable reading for the pharma supply chain middlemen.

The firing of the Federal Trade Commission’s (FTC’s) two remaining Democratic commissioners Wednesday could raise new, ...

A bill designed to force PBMs to pay higher fees to independent drugstores sailed through the state House, but lobbyists are ...

Commissioner Melissa Holyoak, the other Republican on the commission, and Ferguson were recused in the FTC's case accusing ...